Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TAK) Revenue
Annual & quarterly revenue history · segment & region breakdown
TAK · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsTakeda Pharmaceutical Company Limited trailing twelve-month (TTM) revenue is $4547B, an increase of 4.28% year-over-year from $4777B in FY2026.
Revenue trend
2026 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-03-31 | $4777B | +$195.90B | +4.28% |
| 2025-03-31 | $4582B | +$317.79B | +7.45% |
| 2024-03-31 | $4264B | +$236.28B | +5.87% |
| 2023-03-31 | $4027B | +$458.47B | +12.85% |
| 2022-03-31 | $3569B | +$371.19B | +11.61% |
| 2021-03-31 | $3198B | -$93.38B | -2.84% |
| 2020-03-31 | $3291B | +$1193.96B | +56.93% |
| 2019-03-31 | $2097B | +$326.69B | +18.45% |
| 2018-03-31 | $1771B | +$38.48B | +2.22% |
| 2017-03-31 | $1732B | -$75.33B | -4.17% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare TAK revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Takeda Pharmaceutical Company Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Takeda Pharmaceutical Company Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in JPY.
Data sourced from Takeda Pharmaceutical Company Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
TAK revenue · 5 questionsTAK's trailing twelve-month (TTM) revenue is $4547B. That is an increase of 4.28% year-over-year from $4777B in FY2026.
▸ Source: FMP · Takeda Pharmaceutical Company Limited SEC filings · GAAP · Takeda Pharmaceutical Company Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026